In the name of God M.Mohamadian - PowerPoint Presentation

Slide1

In the name of God

M.Mohamadian

Molecular Basis Of

Aortic Aneurysms

Slide2

Definitions A permanent dilatation of 50% or more compared with the expected normal diameter of the vessel.

An arterial dilatation less then 50% of the original Diameter. A diffuse enlargement in several arterial segments greater than 50% in diameter

Arteriomegaly

Ectasia

Aneurysm

Slide3

Aortic Aneurysms 1. Thoracic Aortic Aneurysms

- Marfan syndrome(MFS) - Bicuspid aortic valve(BAV) - Familial thoracic aortic aneurysm syndrome

2. Abdominal Aortic Aneurysms

Slide4

MFS Review- MFS is

a systemic disorder of connective tissue with protean manifestations, with the skeletal, ocular, and cardiovascular systems most often affected.- The hallmark of MFS is abnormality of the medial layer of the aortic wall and the most threatening consequence of MFS is dilatation of the aortic root and the ascending aorta

, which, if untreated, can result in fatal aortic dissection or rupture.

-

Autosomal

-dominant with complete penetrance

.- FBN1

mutations were linked to the majority of the cases of MFS

- In addition, a distinct gene on chromosome 3p24 (

TGFBR2

) was linked to another family with MFS.

Slide5

It is possible that the genes responsible for MFS may also account for the development of the associated thoracic aortopathy, because of a shared embryological origin of the aortic valve and the ascending aorta from the cardiac neural crest cells.

Notice

Slide6

FBN1

Slide7

- TGFβR1,2: Four missense mutations that affect the kinase domains, causing MFS and familial thoracic aortic aneurysm and aortic dissections (TAAD), have been described.

- SMAD3: One frameshift mutation and three missense mutations were identified in individuals with FTAAD, located in exons

2,5, and 6

Dysregulation

of ECM, proliferation and differentiation in aortic wall cells.

TGFBR1, TGFBR2, SMAD3

Slide8

Bicuspid aortic valve disease (BAVD)

- BAVD is the most common congenital cardiac malformation, affecting 1–2% of the population. - BAVD is highly associated with other congenital aorta abnormalities, such as

coarctation

, dilatation of the aortic root or ascending aorta and may progress to frank thoracic aortic aneurysms and aortic dissection.

- The

histopathology in such cases is similar to that of patients with MFS who also have abnormal FBN1 content in their aortic wall.

- Fibrillin-1 deficiency is also observed in the pulmonary arteries of BAV patients and main pulmonary artery dilatation has been noted to occur in association with BAV in the absence of pulmonary valve abnormality.

Slide9

Slide10

Hemodynamic contributions in BAV-TA- Increased expression of MMP2 and a higher MMP2 to TIMP1 activity in tissue samples from aortic aneurysms in BAV patients. matrix degradation, weakening of aortic wall structural integrity, loss of aortic elasticity, progressive aortic dilatation, and aneurysm and/or dissection .

- Reduction of endothelial nitric oxide synthase (eNOS) protein expression, with site-dependent variability, which is probably triggered by variations in shear stress along the aortic wall.

cytosolic

accumulation of HTRA2/Omi, a

proapoptotic

mitochondrial serine protease, which presumably mediates VSMC apoptosis in BAV aortas.- ECM

remodelling occurs early in BAV(during development and valvulogenesis): collagen, laminin ,

fibrillin

and

fibulin

reduction and increases in

fibronectin

and

tenascin

expression. increased Bcl-2-modifying factor-Bcl-2 binding (Bmf-Bcl2), a known matrix-dependent

proapoptotic

, enhanced VSMC apoptotic indices.

Slide11

SO,…BAVD is the result of intrinsic defects in the ECM rather than a secondary consequence of

valvular dysfunction. - Dilatation of the ascending thoracic aorta can be found in young adults with a bicuspid aortic valve but without significant

valvular

stenosis

or regurgitation.- BAVD patients who have undergone aortic valve replacement can develop ascending thoracic aortic aneurysms at a later date.

Evidences

Slide12

Genetic and molecular basis of BAV-TA- BAV is a heritable trait: approximately 9% prevalence amongst first degree relatives, and up to 24% in families with more than one affected family member.

- Genetic heterogeneity with variable patterns of inheritance.

Major related genes

:

-Transcriptional regulator

NOTCH1 gene at chromosome 9q34.3-Homozygous deletion of the

eNOS (Nos3) gene -Cardiac homeobox

Nkx2-5

haploinsufficiency

-Deletion of the cardiac transcription factor

GATA5

(essential factor in

cardiogenesis

and aortic valve development,

endocardial

cell differentiation).

Slide13

NOTCH1- Activation of inflammatory pathways plays a critical role in the development of aneurysm.

- Notch1 signaling is a significant regulator of the inflammatory response. - Overexpression of NOTCH1 increasing inflammatory response in the aorta.

BAV

Slide14

Genetic and molecular basis of BAV-TA - BAV has been observed to occur more frequently in patients with thoracic aortic aneurysm who have mutations in the

FBN1 and ACTA2 genes . - A single nucleotide substitution in the TGFBR2

gene, c1159G>A, which results in an amino acid change (i.e.

missense

mutation) and destabilizes the mutant TGFBR2 protein structure of the aortic media, was segregated in a family with BAV and proximal aortic aneurysm .

- Genome-wide marker-based linkage analyses have provided evidence on the genetic basis of BAV-TA with some families with BAV and ascending aortic aneurysms showing

linkage to chromosome 15q25-26 . although the causal gene(s) are yet to be identified.

Slide15

ACTA2- ACTA2 mutated in 14-20% of people with

thorasic aortic aneurysm The ACTA2 gene smooth muscle alpha (α)-2 actin, which is found in vascular smooth muscle cells.(walls of the aorta)

Sarcomeres

formation which are necessary for muscles to contract. allows the arteries to maintain their shape instead of stretching out as blood is pumped through them.

ACTA2 dominant negative mutations Abnormal stretching of the aorta results in the aortic dilatation, aneurysms, and dissections.

Slide16

further clues - Recently, a comparative study on

global gene expression levels was performed in aortic tissues from patients with bicuspid or tricuspid aortic valve, with and without thoracic aortic aneurysm, Only 7 genes showed differential expression in 2 groups: LEFTY2 (a TGF-β family member), The 4 upregulated

genes FRAS1 (a member of ECM family of protein),

SHC4(

Src

Homology 2 Domain Containing) DAPK3 (a proapoptotic

gene). VEGFC (a member of VEGF family)The 3 downregulated genes NFASC (a member of the L1 family of CAMs)

LSP1 (lymphocyte-specific protein-1).

Slide17

further clues

- BAV patients with aortic dilatation showed an almost exclusive expression of the TGF-β binding proteins LTBP3/4, ADAMTSL1 and an alternatively spliced isoform of Fibronectin-1 (FN1).

Likely

, they have impaired TGF-β mediated splicing mechanisms of

fibronectin

transcript, thereby leading to altered fibronectin expression in the aortic aneurysm tissue and consequently contributing to the increased susceptibility to

aortopathy development in BAV patients.

Slide18

- Familial TAAD is expected to cause about 20% of all cases of thoracic aortic aneurysms and dissections. - This disorder can occur in conjunction with other genetic syndromes including Marfan syndrome,

Loeys-Dietz syndrome, Ehlers-Danolos, and other related syndromes.- Not have identifiable congenital abnormalities.- Absence of overt connective tissue disorders.

- Most pedigrees suggested

autosomal

-dominant of inheritance.

- Variability in the expression and penetrance

- Genetic heterogeneity

Familial thoracic aortic aneurysm syndrome

Slide19

Genetics of familial thoracic aortic aneurysm syndrome

Slide20

MYH11- Account for 2% of non-

syndromic TAAD.- Heterozygous MYH11 mutations result in thoracic aortic aneurysms and are thought to act via a dominant negative mechanism with wild-type MYH11.

Slide21

MYLK- MYLK

encodes three gene products expressed from separate promoters, with two isoforms containing the catalytic and CaM-binding domains and a third, small, non-catalytic protein called

telokin

(that affects calcium sensitivity of contraction).

- Two other

missense

alterations, c.5260G>A and c.5275T>C, disrupt in

calmodulin

-binding sequence and lead to

decreased

MLCK function

- A c.4438C>T (p.Arg1480Ter) mutation located in the MLCK

kinase

domain leads to either nonsense-mediated decay or a truncated protein .

Slide22

Abdominal Aortic Aneurysms(AAA)- AAA is usually

defined as infrarenal aortic diameter >30mm.- AAAs are typically associated with aging and

atherosclerosis

.

- Gender plays a role; men are 10 times more likely than women to have an AAA of 4 cm or greater, BUT women with an AAA have a significantly greater risk of rupture than men.

- Approximately 20 % of the patients with an abdominal aortic aneurysm (AAA) have a positive family history for aneurysms. - Those having a first-degree relative with an AAA have an increased risk of 13–32% compared with the 2–5% risk in the general population.

- Those with familial aneurysms tend to be younger and have higher rates of rupture than those with sporadic aneurysms.

Slide23

Pathophysiology of AAA

Biochemical wall stress.Destructive remodeling of the elastic media of the aortic wallInfiltration of inflammatory cells, including B lymphocytes, T lymphocytes, and macrophages.

Increased

immunoreactivity

for

elastolytic matrix metalloproteases

(MMP), particularly MMP-2, MMP-9, and MMP-12, secreted by the infiltrating macrophages, and cytokines.

Elastolysis

Aortic aneurysms

- Natural reduction in the number of

elastin

layers in the aortic wall in the

infrarenal

aorta.

- Decrease in the collagen content from the proximal to the distal aorta.

- A calcified plaque, a common feature of AAAs, causes increased local wall stress due to the focal stiffness

Slide24

Genetic basis of AAA

- Genes associated with the familial thoracic aortic aneurysm play a role in the degenerative changes of the extracellular matrix of the abdominal aortic wall underlying the formation of AAA.- In addition, an association between abdominal aneurysm and the c.665C>T variant in MTHFR have been investigated.

- There is higher incidence of the allele subtype HLA-DR B1*0401 and HLA-DQA1*0102 in the AAA patient. In contrast, the HLA-DR B1*01 allele tended to behave as a protective factor for AAA.

Slide25

MTHFR- Serum

folate deficiency and hyperhomocysteinemia were associated with an increased risk of AAA - ER stress induced by homocysteine increases gene expression of MMP-3

(ER stress-induced apoptosis in aortic wall cells)

Slide26

Apo-E, NOS

Atherosclerotic lesions, such as those seen in the apo-E mutation, serve as the initial insult leading to a chronic inflammatory state. But not sufficient to induce the formation of aneurysms, a significant endothelial dysfunction (such as lack of the critical endothelial regulator nitric oxide) may be the second factor that accelerates the process of AAA formation.

Mice were more

hypertensive

than control wild-type mice, and a significant proportion of these mice

developed an AAA. The development of the AAA was not simply owing to hypertension, because lowering the blood pressure to levels seen in the control mice had no effect in reducing aneurysm development!

Apo-E Knockout

&

NOS knockout

Slide27

Genetic Associations by meta-analyses. LRP1, LDLR, SORT1

affect cholesterol metabolism and atherosclerosis. LRP1 has other important regulatory roles, including regulation of extracellular matrix breakdown by the endocytosis of proteinases

.

LPA

produces lipoprotein A, which increases cardiovascular risk.

IL6R polymorphisms alter cardiovascular risk, possibly through

inflammation.MMP3 affects atherosclerosis and tissue remodelling

.

AGTR1

affects blood pressure, which is consistent with the association

between hypertension and AAA.

DAB2IP

is a

tumour

suppressor gene involved in cell

signalling

, survival, migration, maturation, and apoptosis.

Slide28

- Inhibitors of MMPs (doxycycline and BB-94) or other proteases such as

cathepsins and plasminogen-activator inhibitor (PAI-1) offers a tremendous .therapeutic strategy to prevent AAA enlargement

- Inflammation plays an integral role in the development of AAA and expression of the inflammatory molecule,

cyclooxygenase

(COX)-2, is increased in

aneurysmal tissues: NSAIDs (celecoxib

) decreased the incidence and severity of AAA formation- C-Jun N-Terminal Kinase (JNK) is highly active in human AAA walls and specific inhibition of JNK can significantly suppress the secretion of MMP-9 and prevent collagen degradation.

JNK inhibition

may play a significant role in impeding the progression of AAA.

Pharmacotherapy

Slide29

Slide30

ReferencesD.T. Bradley a, S.A. Badger et al.

Abdominal Aortic Aneurysm Genetic Associations: Mostly False? A Systematic Review and Meta-analysis. Eur J Vasc Endovasc Surg (2016) 51, 64-75Koen M. van de Luijtgaarden

et al.

First genetic analysis of aneurysm genes in familial and sporadic abdominal aortic aneurysm

. Hum Genet (2015)

.134:881–893

Ratnasari Padang, Paul G. Bannon et al. The genetic and molecular basis of bicuspid aortic valve associated thoracic

aortopathy

: a link to phenotype

heterogeneity.

Ann

Cardiothorac

Surg

2013;2(1):83-91

Suman

Annambhotla

, Sebastian Bourgeois et al.

Recent Advances in Molecular Mechanisms of Abdominal Aortic Aneurysm Formation.

World J Surg. 2008 June ; 32(6): 976–986

Slide31

Thank you very much for

your

patience!